 | Up a level |
von Laffert, M; Hunger, R E; Navarini, A A; Zouboulis, C C (2021). [Erratum to: Clinical, pathology-associated and molecular biomarkers of hidradenitis suppurativa/acne inversa]. Der Hautarzt, 72(9), p. 842. Springer 10.1007/s00105-021-04878-2
von Laffert, M; Hunger, R E; Navarini, A A; Zouboulis, C C (2021). [Clinical, pathology-associated and molecular biomarkers of hidradenitis suppurativa/acne inversa]. Der Hautarzt, 72(8), pp. 666-675. Springer 10.1007/s00105-021-04848-8
Zouboulis, C C; Tzellos, T; Kyrgidis, A; Jemec, G B E; Bechara, F G; Giamarellos-Bourboulis, E J; Ingram, J R; Kanni, T; Karagiannidis, I; Martorell, A; Matusiak, Ł; Pinter, A; Prens, E P; Presser, D; Schneider-Burrus, S; von Stebut, E; Szepietowski, J C; van der Zee, H H; Wilden, S M and Sabat, R (2017). Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. British journal of dermatology, 177(5), pp. 1401-1409. Wiley-Blackwell 10.1111/bjd.15748
Saunte, D M; Boer, J; Stratigos, A; Szepietowski, J C; Hamzavi, I; Kim, K H; Zarchi, K; Antoniou, C; Matusiak, L; Lim, H W; Williams, M; Kwon, H H; Gürer, M A; Mammadova, F; Kaminsky, A; Prens, E; van der Zee, H H; Bettoli, V; Zauli, S; Hafner, J; ... (2015). Diagnostic delay in hidradenitis suppurativa is a global problem. British journal of dermatology, 173(6), pp. 1546-1549. Wiley-Blackwell 10.1111/bjd.14038
Zouboulis, C C; Desai, N; Emtestam, L; Hunger, Robert; Ioannides, D; Juhász, I; Lapins, J; Matusiak, L; Prens, E P; Revuz, J; Schneider-Burrus, S; Szepietowski, J C; van der Zee, H H; Jemec, G B E (2015). European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. Journal of the European Academy of Dermatology and Venereology, 29(4), pp. 619-644. Blackwell 10.1111/jdv.12966
